These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 758812)

  • 1. Serum prolactin and clinical state during neuroleptic treatment and withdrawal.
    Laughren TP; Brown WA; Williams BW
    Am J Psychiatry; 1979 Jan; 136(1):108-10. PubMed ID: 758812
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative trial of haloperidol and thioridazine: management of chronic schizophrenia.
    Weston MJ; Bentley R; Unwin A; Morris M; Harper MA
    Aust N Z J Psychiatry; 1973 Mar; 7(1):52-7. PubMed ID: 4579393
    [No Abstract]   [Full Text] [Related]  

  • 3. Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients.
    Rao ML; Brown WA
    Psychopharmacology (Berl); 1987; 93(2):237-42. PubMed ID: 2892222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptation.
    Kirkpatrick B; Buchanan RW; Maeda K; Carpenter WT; Jauch D; Tamminga CA
    Biol Psychiatry; 1989 Jun; 26(2):131-8. PubMed ID: 2567610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low serum prolactin and early relapse following neuroleptic withdrawal.
    Brown WA; Laughren T
    Am J Psychiatry; 1981 Feb; 138(2):237-9. PubMed ID: 6109456
    [No Abstract]   [Full Text] [Related]  

  • 6. Tolerance to the prolactin-elevating effect of neuroleptics.
    Brown WA; Laughren TP
    Psychiatry Res; 1981 Dec; 5(3):317-22. PubMed ID: 6119716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of haloperidol and thioridazine HC1 in chronic treatment-resistant schizophrenics.
    Gonier T; Schiele BC; Vestre ND
    Behav Neuropsychiatry; 1970; 2(3):47-9 passim. PubMed ID: 4913152
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-blind study of thioridazine and haloperidol in geriatric patients with a psychosis associated with organic brain syndrome.
    Cowley LM; Glen RS
    J Clin Psychiatry; 1979 Oct; 40(10):411-9. PubMed ID: 489517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thioridazine HC1 Vs. chlordiazepoxide HC1 in controlling symptoms attributable to alcohol withdrawal.
    Pena-Ramos A
    Dis Nerv Syst; 1977 Mar; 38(3):143-7. PubMed ID: 837817
    [No Abstract]   [Full Text] [Related]  

  • 10. Haloperidol versus thioridazine in the treatment of behavioral symptoms in senile dementia of the Alzheimer's type: preliminary findings.
    Steele C; Lucas MJ; Tune L
    J Clin Psychiatry; 1986 Jun; 47(6):310-2. PubMed ID: 3711028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin shifts after neuroleptic withdrawal.
    Green AI; Faraone SV; Brown WA
    Psychiatry Res; 1990 Jun; 32(3):213-9. PubMed ID: 1975101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haloperidol and thioridazine in treatment of chronic schizophrenics.
    Prasad L; Townley MC
    Dis Nerv Syst; 1966 Nov; 27(11):722-6. PubMed ID: 5925664
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind comparison of haloperidol (Haldol) and thioridazine (Mellaril) in outpatient children.
    Claghorn JL
    Curr Ther Res Clin Exp; 1972 Dec; 14(12):785-9. PubMed ID: 4629817
    [No Abstract]   [Full Text] [Related]  

  • 14. Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study.
    Tsuang MM; Lu LM; Stotsky BA; Cole JO
    J Am Geriatr Soc; 1971 Jul; 19(7):593-600. PubMed ID: 4937658
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum prolactin correlates with depressed mood during alcohol withdrawal.
    Miller F; Barasch A; Sacks M; Levitan J; Ashcroft L
    Drug Alcohol Depend; 1986 Jul; 17(4):331-8. PubMed ID: 3757769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new view of the evaluation of alcohol withdrawal and alcohol dependence].
    Samochowiec J; Horodnicki J
    Psychiatr Pol; 1995; 29(1):139-49. PubMed ID: 7878150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum prolactin as a correlate of clinical response to haloperidol.
    Van Putten T; Marder SR; Mintz J
    J Clin Psychopharmacol; 1991 Dec; 11(6):357-61. PubMed ID: 1770154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin.
    Bjørndal N; Bjerre M; Gerlach J; Kristjansen P; Magelund G; Oestrich IH; Waehrens J
    Psychopharmacology (Berl); 1980 Jan; 67(1):17-23. PubMed ID: 6768075
    [No Abstract]   [Full Text] [Related]  

  • 19. The interaction between superoxide dismutase and prolactin is involved in response to haloperidol and risperidone treatment in schizophrenia: a double-blind and randomized study.
    Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC
    J Clin Psychopharmacol; 2006 Feb; 26(1):103-5. PubMed ID: 16415724
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatients.
    Kirkpatrick B; Carpenter WT; Maeda K; Buchanan RW; Breier A; Tamminga CA
    Biol Psychiatry; 1992 Dec; 32(11):1049-54. PubMed ID: 1467385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.